PL2097137T3 - Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia - Google Patents

Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia

Info

Publication number
PL2097137T3
PL2097137T3 PL07817968T PL07817968T PL2097137T3 PL 2097137 T3 PL2097137 T3 PL 2097137T3 PL 07817968 T PL07817968 T PL 07817968T PL 07817968 T PL07817968 T PL 07817968T PL 2097137 T3 PL2097137 T3 PL 2097137T3
Authority
PL
Poland
Prior art keywords
periodontitis
diseases
gingivitis
manifestation
strontium
Prior art date
Application number
PL07817968T
Other languages
English (en)
Inventor
John Nikolaj Hvarre Christensen
Original Assignee
Mokwalo Spf S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mokwalo Spf S A filed Critical Mokwalo Spf S A
Publication of PL2097137T3 publication Critical patent/PL2097137T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL07817968T 2006-11-21 2007-11-20 Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia PL2097137T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601522 2006-11-21
EP07817968A EP2097137B1 (en) 2006-11-21 2007-11-20 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.
PCT/DK2007/050172 WO2008061535A1 (en) 2006-11-21 2007-11-20 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.

Publications (1)

Publication Number Publication Date
PL2097137T3 true PL2097137T3 (pl) 2013-02-28

Family

ID=39099797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07817968T PL2097137T3 (pl) 2006-11-21 2007-11-20 Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia

Country Status (7)

Country Link
US (2) US20100272802A1 (pl)
EP (1) EP2097137B1 (pl)
DK (1) DK2097137T3 (pl)
ES (1) ES2395740T3 (pl)
PL (1) PL2097137T3 (pl)
PT (1) PT2097137E (pl)
WO (1) WO2008061535A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
NL2004260C2 (en) * 2010-02-18 2011-08-22 Univ Amsterdam Disinfectant composition and its use in dental treatment.
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
CN114028327B (zh) * 2021-12-24 2023-09-12 西岭(镇江)医疗科技有限公司 一种含依克多因和氯化锶口腔用中药抑菌凝胶及其制备、使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt
AU2005256317B2 (en) * 2004-06-25 2011-09-15 Mokwalo Spf S.A. Compositions comprising strontium and vitamin D and uses thereof

Also Published As

Publication number Publication date
PT2097137E (pt) 2013-01-08
US20100272802A1 (en) 2010-10-28
ES2395740T3 (es) 2013-02-14
EP2097137A1 (en) 2009-09-09
DK2097137T3 (da) 2013-01-14
US20170157001A1 (en) 2017-06-08
WO2008061535A1 (en) 2008-05-29
EP2097137B1 (en) 2012-09-19
ES2395740T8 (es) 2013-12-13

Similar Documents

Publication Publication Date Title
IL250858B (en) A tetracycline compound, a pharmaceutical composition comprising the tetracycline compound, and the tetracycline compound or the pharmaceutical composition for treating a tetracycline responsive state
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
WO2006136607A3 (de) Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
IL189439A0 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
IL200746A0 (en) Cyclopamine analog compounds, compositions comprising the same and uses thereof
IL203915A (en) Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
HK1092722A1 (en) Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
HK1127877A1 (en) Composition containing peptide as the active ingredient
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2009077500A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
AU2003220240A8 (en) Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ( akba ), industrial manufacture and their uses
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
EP2070532A4 (en) OIL / WATER / OIL EMULSION CONTAINING LIGNAN COMPOUND, AND COMPOSITION CONTAINING THE SAME
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2007003264A3 (de) Polyasparaginsäurederivate in polysiloxan-haltigen beschichtungsmitteln
WO2009095423A3 (en) Oral care composition for combating dentine hypersensitivity
PL2097137T3 (pl) Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia
IL181216A (en) 5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
WO2008050157A3 (en) Ozonated oil formulations
WO2007098924A3 (de) Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung
WO2010114305A3 (ko) 페길레이션된 베튤린 유도체 및 그를 포함하는 화장료 조성물
WO2007117926A3 (en) Stable dental whitening compositions